Home Healthcare Pharmaceuticals Thrombosis Drugs Market

Thrombosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Antiplatelet Agents, Anticoagulants, Thrombolytics, Others), By Disease Type (Arterial Thrombosis, Venous Thrombosis, Pulmonary Embolism, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 15, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Thrombosis Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Antiplatelet Agents
    2. Anticoagulants
      1. Heparin
      2. Warfarin
      3. Apixaban
      4. Others
    3. Thrombolytics
    4. Others
  2. Thrombosis Drugs Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Arterial Thrombosis
    2. Venous Thrombosis
    3. Pulmonary Embolism
    4. Others
  3. Thrombosis Drugs Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Injectable
  4. Thrombosis Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  5. Regional Thrombosis Drugs Market
    1. North America
      1. North America Thrombosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
      2. North America Thrombosis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Arterial Thrombosis
        2. Venous Thrombosis
        3. Pulmonary Embolism
        4. Others
      3. North America Thrombosis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      4. North America Thrombosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.S.
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      6. Canada
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
    2. Europe
      1. Europe Thrombosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
      2. Europe Thrombosis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Arterial Thrombosis
        2. Venous Thrombosis
        3. Pulmonary Embolism
        4. Others
      3. Europe Thrombosis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      4. Europe Thrombosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. U.K.
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      6. Germany
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      7. France
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      8. Spain
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      9. Italy
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      10. Russia
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      11. Nordic
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      12. Benelux
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      13. Rest of Europe
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
    3. APAC
      1. APAC Thrombosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
      2. APAC Thrombosis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Arterial Thrombosis
        2. Venous Thrombosis
        3. Pulmonary Embolism
        4. Others
      3. APAC Thrombosis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      4. APAC Thrombosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. China
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      6. Korea
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      7. Japan
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      8. India
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      9. Australia
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      10. Taiwan
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      11. South East Asia
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      12. Rest of Asia-Pacific
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Thrombosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
      2. Middle East and Africa Thrombosis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Arterial Thrombosis
        2. Venous Thrombosis
        3. Pulmonary Embolism
        4. Others
      3. Middle East and Africa Thrombosis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      4. Middle East and Africa Thrombosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. UAE
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      6. Turkey
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      7. Saudi Arabia
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      8. South Africa
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      9. Egypt
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      10. Nigeria
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      11. Rest of MEA
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
    5. LATAM
      1. LATAM Thrombosis Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
      2. LATAM Thrombosis Drugs Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Arterial Thrombosis
        2. Venous Thrombosis
        3. Pulmonary Embolism
        4. Others
      3. LATAM Thrombosis Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      4. LATAM Thrombosis Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. Brazil
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      6. Mexico
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      7. Argentina
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      8. Chile
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      9. Colombia
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
      10. Rest of LATAM
        1. Antiplatelet Agents
        2. Anticoagulants
          1. Heparin
          2. Warfarin
          3. Apixaban
          4. Others
        3. Thrombolytics
        4. Others
        5. Arterial Thrombosis
        6. Venous Thrombosis
        7. Pulmonary Embolism
        8. Others
        9. Oral
        10. Injectable
        11. Hospital Pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.